A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma

Cancer

Volumn 88, Issue 8, 2000, Pages 1781-1787

  Blazeby, Jane M ^a   Farndon, John R ^a   Donovan, Jenny ^b   Alderson, Derek ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Esophageal carcinoma; Esophagectomy; European Organization for Research and Treatment of Cancer (EORTC) QLQ C30; Intubation; Quality of life

Indexed keywords

ADULT; AGED; ANOREXIA; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER STAGING; CLINICAL TRIAL; DYSPHAGIA; EMOTIONAL STRESS; ESOPHAGUS CARCINOMA; ESOPHAGUS INTUBATION; ESOPHAGUS RESECTION; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SURVIVAL TIME; SYMPTOM;

AGED; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; INTUBATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PALLIATIVE CARE; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0034655228     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000415)88:8<1781::AID-CNCR4>3.0.CO;2-G     Document Type: Article

References (26)

1. Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77:845-57.
2. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Oesophageal cancer. Curr Probl Surg 1997;34:765-834.
3. Barr H, Krasner N. Prospective quality-of-life analysis after palliative photoablation for the treatment of malignant dysphagia. Cancer 1991;68:1660-4.
4. Loizou LA, Rampton D, Atkinson M, Robertson C, Bown SG. A prospective assessment of quality of life after endoscopic intubation and laser therapy for malignant dysphagia. Cancer 1992;70:386-91.
5. van Knippenberg FCE, Out JJ, Tilanus HW, Mud HJ, Hop WCJ, Verhage F. Quality of life in patients with resected oesophageal cancer. Soc Sci Med 1992;35:139-45.
6. O'Hanlon D, Harkin M, Daya K, Sergeant T, Hayes N, Griffin SM. Quality of life assessment in patients undergoing treatment for oesophageal carcinoma. Br J Surg 1995;82:1682-5.
7. Zieren HU, Jacobi CA, Zieren J, Muller JM. Quality of life following resection of oesophageal carcinoma. Br J Surg 1996;83:1772-5.
8. Bamias A, Hill ME, Cunningham D, Norman AR, Ahmed FY, Webb A, et al. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for oesophagogastric adenocarcinoma. Cancer 1996;77:1978-85.
9. Webb A, Cunningham D, Scarffe JH, Norman A, Joffe JK, Hughes M, et al. Randomised trial comparing epirubicin, cisplatin and fluorouracil versus fluorouracil, doxorubicin and methrotrexate in advanced oesophagogastric cancer. J Clin Oncol 1997;15:261-7.
10. Farndon MA, Wayman J, Clague MB, Griffin SM. Cost-effectiveness in the management of patients with oesophageal cancer. Br J Surg 1998;85:1394-8.
11. Girling DJ. British Medical Research Council protocol OE02: randomised controlled clinical trial of surgery with or without preoperative chemotherapy in the treatment of resectable cancer of the oesophagus. Cambridge, England: Cancer Trials Office, 1993.
12. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
13. Blazeby JM, Alderson D, Winstone K, Steyn R, Hammerlid E, Arraras J, et al. Development of a EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. Eur J Cancer 1996;32:1912-7.
14. Blazeby JM, Conroy T, Alderson D, Farndon JR, Arraras J, Hammerlid E, et al. An international field study to test the EORTC QLQ-C30 and oesophageal cancer module (EORTC QLQ-OES24) among patients with oesophageal cancer. EORTC Protocol No. 15961/40973, 1997.
15. Vickers J, Alderson D. Oesophageal cancer staging using endoscopie ultrasonography. Br J Surg 1998;85:994-8.
16. Vilmann P, Hancke S, Henriksen FW, Jacobsen GK. Endosonographically guided fine needle aspiration biopsy of malignant lesions in the upper gastrointestinal tract. Endoscopy 1993;25:523-7.
17. Watt I, Stewart I, Anderson D, Bell G, Anderson JR. Laparoscopy, ultrasound and computed tomography in cancer of the oesophagus and gastric cardia: a prospective comparison for detecting intra-abdominal metastases. Br J Surg 1989;76:1036-9.
18. Hopwood P, Stephens RJ, Machin D, for the MRC Lung Cancer Working Party. Approaches to the analysis of quality of life data: experiences gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trial. Qual Life Res 1994;3:339-52.
19. Curran D, Molenberghs G, Fayers PM, Machin D. Incomplete quality of life data in randomized trials: missing forms, Stat Med 1998;17:697-709.
20. Gelber RD, Cole BF, Gelber S, Goldhirsch A. Comparing treatments using quality-adjusted survival: the Q-TWiST method. Am Stat 1995;49:161-9.
21. Weinberger M, Oddone EZ, Samsa G, Landsman P. Are health related quality of life measures affected by the mode of administration? ; Clin Epidemiol 1996;49:135-40.
22. Blazeby JM, Williams MH, Brookes ST, Alderson D, Farndon JR. Quality of life measurement in patients with oesophageal cancer. Gut 1995;37:505-8.
23. Earlam R, Cunha-Melo IR. Oesophageal squamous cell carcinoma. 1. A critical review of surgery. Br J Surg 1980;67:381-90.
24. Mellow MH, Pinkas H. Endoscopic laser therapy for malignancies affecting the esophagus and gastroesophageal junction. Arch Intern Med 1985;145:1443-6.
25. Vacanti CJ, van Houten RJ, Hill RC. A statistical analysis of the relationship of physical status to post operative mortality in 68,388 cases. Anesth Analg 1970;49:564.
26. Hermanek P, Sobin LH. Digestive system tumours. In: Hermanek P, Sobin LH, editors. International Union Against Cancer. TNM classification of malignant tumours. Berlin: Springer-Verlag, 1992.